Invention Grant
- Patent Title: Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders
-
Application No.: US17326270Application Date: 2021-05-20
-
Publication No.: US11597726B2Publication Date: 2023-03-07
- Inventor: Pavel Osten , Kristin K. Baldwin , Robert DeVita , Samuel Desjardins , Jeffrey Albert
- Applicant: Certego Therapeutics Inc.
- Applicant Address: US MA Boston
- Assignee: Certego Therapeutics Inc.
- Current Assignee: Certego Therapeutics Inc.
- Current Assignee Address: US MA Boston
- Agency: Jones Day
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/437 ; A61K45/06 ; A61P25/24
Abstract:
Ring deuterated gaboxadol is provided. The ring deuterated gaboxadol is useful in the treatment of psychiatric disorders and is more effective than non-deuterated gaboxadol in such treatments. Deuterated gaboxadol is useful in combinations with other compounds to provide additive and synergistic effects for patient therapies. In a specific embodiment, the deuterated gaboxadol is d6-gaboxadol.
Public/Granted literature
- US20220127261A1 RING DEUTERATED GABOXADOL AND ITS USE FOR THE TREATMENT OF PSYCHIATRIC DISORDERS Public/Granted day:2022-04-28
Information query
